Natural History Study of Azathioprine Adherence
This study has been completed.
Sponsor:
Thomas E. Nivens, MD
Information provided by (Responsible Party):
Thomas E. Nevins, University of Minnesota - Clinical and Translational Science Institute
ClinicalTrials.gov Identifier:
NCT00143910
First received: September 1, 2005
Last updated: May 17, 2013
Last verified: September 2005
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | September 1, 2005 | ||||
| Last Updated Date | May 17, 2013 | ||||
| Start Date ICMJE | April 1993 | ||||
| Primary Completion Date | October 1999 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
acute transplant rejection [ Time Frame: 10 years ] [ Designated as safety issue: No ] | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | Complete list of historical versions of study NCT00143910 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
Allograft loss [ Time Frame: 10 years ] [ Designated as safety issue: No ] | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Natural History Study of Azathioprine Adherence | ||||
| Official Title ICMJE | Measurement of Compliance in Renal Transplant Recipients | ||||
| Brief Summary | This study began in 1993 as a prospective, natural history study of renal transplant patients' medication compliance measured by using an electronic monitor on the cap of medication vials. Hypothesis: Poor medication compliance predicts adverse outcomes. Enrollment is closed. |
||||
| Detailed Description |
|
||||
| Study Type ICMJE | Observational | ||||
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Prospective |
||||
| Target Follow-Up Duration | Not Provided | ||||
| Biospecimen | Not Provided | ||||
| Sampling Method | Non-Probability Sample | ||||
| Study Population | Successful renal transplant recipients, discharged from hospital with a functioning renal transplant. |
||||
| Condition ICMJE | Kidney Transplant | ||||
| Intervention ICMJE | Other: observation | ||||
| Study Group/Cohort (s) | Renal transplant recipient
Recipients of successful renal transplant
Intervention: Other: observation |
||||
| Publications * | Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int. 2001 Oct;60(4):1565-70. | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 180 | ||||
| Completion Date | October 1999 | ||||
| Primary Completion Date | October 1999 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 16 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00143910 | ||||
| Other Study ID Numbers ICMJE | 9109M04306, NIH - DK13083 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | Thomas E. Nevins, University of Minnesota - Clinical and Translational Science Institute | ||||
| Study Sponsor ICMJE | Thomas E. Nivens, MD | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | University of Minnesota - Clinical and Translational Science Institute | ||||
| Verification Date | September 2005 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||